The aim of this study is to identify the PSMA-ligand binding in patients with early and advanced stages of PCa by measuring changes in the PSMA uptake in various organs, including non-physiologically PSMA-expressing organs, as differences in PSMA expression could lead to unpredictable radiotoxicity in early-stage PCa patients. This evidence concerns the gene FOLH1 and posterior cortical atrophy.